Ranger Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-156,717
| Closed | -$12.4M | – | 146 |
|
|
2017
Q2 | $12.4M | Sell |
156,717
-127,237
| -45% | -$10M | 0.88% | 48 |
|
|
2017
Q1 | $23.6M | Sell |
283,954
-20,351
| -7% | -$1.69M | 1.71% | 30 |
|
|
2016
Q4 | $24.1M | Sell |
304,305
-8,350
| -3% | -$663K | 1.71% | 28 |
|
|
2016
Q3 | $21.9M | Sell |
312,655
-76,500
| -20% | -$5.36M | 1.57% | 27 |
|
|
2016
Q2 | $15.1M | Sell |
389,155
-15,000
| -4% | -$582K | 0.93% | 50 |
|
|
2016
Q1 | $16.4M | Sell |
404,155
-4,760
| -1% | -$193K | 1% | 43 |
|
|
2015
Q4 | $36.3M | Sell |
408,915
-19,380
| -5% | -$1.72M | 2.14% | 15 |
|
|
2015
Q3 | $31.7M | Sell |
428,295
-27,630
| -6% | -$2.05M | 1.79% | 26 |
|
|
2015
Q2 | $36.9M | Buy |
+455,925
| New | +$36.9M | 1.8% | 22 |
|